Titlebook: Stroke Revisited: Diabetes in Stroke; Seung-Hoon Lee,Dong-Wan Kang Book 2021 The Editor(s) (if applicable) and The Author(s), under exclus

只看該作者 · 發(fā)表于 2025-3-27 04:39:41

SGLT2 Inhibitorsomes independent of diabetes status, and even in patients at high risk of renal progression or HF. Future experimental studies are necessary to know whether SGLT2 inhibitors could be used as a goal-directed medical therapy in HF or CKD.

只看該作者 · 發(fā)表于 2025-3-27 06:26:21

只看該作者 · 發(fā)表于 2025-3-27 10:54:26

只看該作者 · 發(fā)表于 2025-3-27 17:30:49

Future Therapies for Diabetess can mature into glucose-responsive beta cells after the transplant in vivo and transplantation methods are available. In addition, gene therapy studies are also being conducted. Other promising therapies include xenotransplantation of porcine pancreatic islets. In this review, I describe their adv

只看該作者 · 發(fā)表于 2025-3-27 20:53:26

Principles of Diabetes Care and Lifestyle Modification

只看該作者 · 發(fā)表于 2025-3-28 01:17:35

只看該作者 · 發(fā)表于 2025-3-28 03:45:57

只看該作者 · 發(fā)表于 2025-3-28 07:54:17

只看該作者 · 發(fā)表于 2025-3-28 14:26:29

		自動(dòng)登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點(diǎn)評(píng)	投稿經(jīng)驗(yàn)總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-28 06:30
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved